Modal Labs secured $750 million in a Series D round led by Accel, reaching a valuation of $15.75 billion. The company reports an annual revenue run rate exceeding $1 billion.
Construction technology firm Icon raised $200 million in Series D funding led by Baillie Gifford and BlackRock. The company anticipates 4x revenue growth in 2026.
Soufflé Therapeutics raised $135 million in Series B funding, while Estuary Biotherapeutics secured $103 million, comprising a $93 million Series A and $10 million in seed capital.
Labelbox closed a $100 million Series E round led by Infinitum Partners. Suki obtained $90 million in Series E funding, and Abby Care secured $82 million in a Series C round.
Stand raised $70 million in Series C funding at a $1 billion valuation. Additionally, Mueon Corp. completed a $65 million Series A, and North.cloud raised $60 million in Series B.
